Please assess the completion status of the following clinical trial:

Trial Title: Radiofrequency Ablation for Amiodarone-induced Thyrotoxicosis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Are adults~* Have overt thyrotoxicosis (within 2 weeks prior to enrollment)~* Are receiving medical therapy for AIT~* Are able to understand the study procedures and to comply with them for the entire length of the study~* Have not normalized their thyroid levels after one month of standard therapy or~* Have persistent and clinically significant thyrotoxicosis (less than 25% decrease in T4 value or patients requiring hospitalization with Congestive heart failure (CHF), tachyarrhythmias, hemodynamic instability or similar co-morbidities) after 2 weeks of standard therapy where additional medical therapy is deemed unlikely to be beneficial or with high risk of side-effects (e.g. hepatotoxicity of antithyroid medications, agranulocytosis of potassium perchlorate or ATD or fluid retention associated with steroids).~Exclusion Criteria:~* Pregnancy~* Patients with prior neck surgery or neck radiation~* Patients with neck anatomy that precludes easy access by RFA to the entirety of thyroid parenchyma~* Patients on anticoagulation therapy~* Patients with comorbidities deemed too high of a risk for general anesthesia~* Treatment with another investigational drug or intervention (within 6 weeks of planned RFA).~* Current drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements.~* Inability or unwillingness of individual or legal guardian/representative to give written informed consent.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- RFA group (Type: EXPERIMENTAL): RFA

Based on this trial design, predict the completion outcome and termination type (if applicable).